Inactive Instrument

News Bone Biologics Corp OTC Bulletin Board

Equities

US0980701058

End-of-day quote OTC Bulletin Board Other stock markets
- ^USD	-

04/05	Certain Common Stock of Bone Biologics Corporation are subject to a Lock-Up Agreement Ending on 4-MAY-2024.	CI
04/05	Certain Warrants of Bone Biologics Corporation are subject to a Lock-Up Agreement Ending on 4-MAY-2024.	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Certain Common Stock of Bone Biologics Corporation are subject to a Lock-Up Agreement Ending on 4-MAY-2024.	04/05	CI
Certain Warrants of Bone Biologics Corporation are subject to a Lock-Up Agreement Ending on 4-MAY-2024.	04/05	CI
Certain Stock Options of Bone Biologics Corporation are subject to a Lock-Up Agreement Ending on 4-MAY-2024.	04/05	CI
Bone Biologics Announces Closing of $2.0 Million Public Offering	07/03	BU
Bone Biologics Announces Pricing of $2.0 Million Public Offering	04/03	BU
Bone Biologics Corporation Reports Progress with NB1 Clinical Program	01/03	CI
Bone Biologics Reports Progress With NB1 Clinical Program	01/03	BU
Bone Biologics Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	22/02	CI
Bone Biologics Appoints Healthcare Finance Veteran Robert E. Gagnon to Board of Directors	11/01	BU
Bone Biologics Corporation Announces Board Changes	11/01	CI
Bone Biologics Regains Compliance with Nasdaq Continued Listing Requirements	10/01	BU
Bone Biologics Corporation Announces the Resignation of Erick Lucera as Director	03/01	CI
Bone Biologics' 1-for-8 Reverse Stock Split Takes Effect Wednesday	19/12	MT
Bone Biologics Announces 1-for-8 Reverse Stock Split	18/12	BU
Bone Biologics Closes Common Stock Offering; Shares Fall After Hours	21/11	MT
Bone Biologics Announces Closing of Registered Direct Offering Priced At-the-Market Under Nasdaq Rules	20/11	BU
Bone Biologics Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules	17/11	BU
Bone Biologics Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	15/11	CI
Nano-Cap Medical Technology Watchlist (ORHB, BBLG, ICU, RMTI)	02/23/02	AQ
Bone Biologics Provides Scientific Update on NB1 Bone Graft Device	26/23/26	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Bone Biologics Corp OTC Bulletin Board

Equities

US0980701058

Summary

Filters